CANCER
1PMPyU0
1PMPyU0
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Bloodwise 58<br />
Notes to the Accounts for the year ended 31 March 2015<br />
Notes to the accounts for the year<br />
ended 31 March 2015 (continued)<br />
5 TANGIBLE ASSETS – GROUP AND BLOODWISE<br />
Freehold<br />
Land &<br />
Buildings<br />
Fixtures,<br />
Equipment<br />
& Vehicles<br />
Total<br />
£’000 £’000 £’000<br />
Cost<br />
At 1 April 2014 1,965 765 2,730<br />
At 31 March 2015 1,965 765 2,730<br />
Depreciation<br />
At 1 April 2014 197 577 774<br />
Charge for the year 20 77 97<br />
At 31 March 2015 217 654 871<br />
Net Book Value<br />
At 31 March 2015 1,748 111 1,859<br />
At 31 March 2014 1,768 188 1,956<br />
6 INVESTMENTS – GROUP AND BLOODWISE<br />
2015 2014<br />
£’000 £’000<br />
Market value of investments<br />
at 1 April 64,079 71,893<br />
Additions at cost 7,653 7,147<br />
Disposal proceeds (34,062) (15,758)<br />
Net investment gains 3,469 797<br />
Market value of investments<br />
at 31 March 41,139 64,079<br />
Cash held as part of investment<br />
portfolio 24,613 10,398<br />
Total with investment managers 65,752 74,477<br />
Bloodwise trading as Leukaemia & Lymphoma Research Company limited by guarantee 738089<br />
Registered charity 216032 (England & Wales) SC037529 (Scotland)
Change language